Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Luisa Yee is active.

Publication


Featured researches published by Luisa Yee.


Vaccine | 2010

Heat-stable measles vaccine produced by spray drying

Satoshi Ohtake; Russell A. Martin; Luisa Yee; Dexiang Chen; Debra Kristensen; David Lechuga-Ballesteros; Vu Truong-Le

A combination of unique stabilizers and mild spray drying process conditions was employed to produce heat-stable measles vaccine powder. Live attenuated measles vaccine from Serum Institute of India was formulated with pharmaceutically approved stabilizers, including sugars, proteins, amino acids, polymers, surfactants, and plasticizers, as well as charged ions. In addition, the effects of buffer salt and pH on the storage stability of measles virus were examined. The potency of the dried vaccine stored at several temperatures was quantified by TCID(50) assay on Vero cells. As a comparison to other process methods, lead formulations were also subjected to freeze drying and foam drying. The optimized measles vaccine formulation tested at 37 degrees C was stable for approximately 8 weeks (i.e. time for 1 log TCID(50) loss). The measles titer decreased in a bi-phasic manner, with initial rapid loss within the first week but relative stability thereafter. Key stabilizers identified during the formulation screening processes were L-arginine, human serum albumin, and a combination of divalent cations. Spray drying was identified as the optimal processing method for the preparation of dried vaccine, as it generally resulted in negligible process loss and comparable, if not better storage stability, with respect to the other processes. Processing methods and formulation components were developed that produced a measles vaccine stable for up to 8 weeks at 37 degrees C, which surpassed the WHO requirement for heat stability of 1 week at that temperature.


Journal of Pharmaceutical Sciences | 2011

Biophysical Characterization and Conformational Stability of Ebola and Marburg Virus-Like Particles

Lei Hu; Jared M. Trefethen; Yuhong Zeng; Luisa Yee; Satoshi Ohtake; David Lechuga-Ballesteros; Kelly L. Warfield; M. Javad Aman; Sergey Shulenin; Robert Unfer; Sven Enterlein; Vu Truong-Le; David B. Volkin; Sangeeta B. Joshi; C. Russell Middaugh

The filoviruses, Ebola virus and Marburg virus, cause severe hemorrhagic fever with up to 90% human mortality. Virus-like particles of EBOV (eVLPs) and MARV (mVLPs) are attractive vaccine candidates. For the development of stable vaccines, the conformational stability of these two enveloped VLPs produced in insect cells was characterized by various spectroscopic techniques over a wide pH and temperature range. Temperature-induced aggregation of the VLPs at various pH values was monitored by light scattering. Temperature/pH empirical phase diagrams (EPDs) of the two VLPs were constructed to summarize the large volume of data generated. The EPDs show that both VLPs lose their conformational integrity above about 50°C-60°C, depending on solution pH. The VLPs were maximally thermal stable in solution at pH 7-8, with a significant reduction in stability at pH 5 and 6. They were much less stable in solution at pH 3-4 due to increased susceptibility of the VLPs to aggregation. The characterization data and conformational stability profiles from these studies provide a basis for selection of optimized solution conditions for further vaccine formulation and long-term stability studies of eVLPs and mVLPs.


Human Vaccines | 2010

Biophysical characterization of rotavirus serotypes G1, G3, and G4

Reza Esfandiary; Luisa Yee; Satoshi Ohtake; Russell A. Martin; Vu Truong-Le; David Lechuga-Ballesteros; David D. Moore; Sangeeta B. Joshi; C. Russell Middaugh

The stability of attenuated virus vaccines has traditionally been assessed by a plaque assay to measure the virus’s loss of replication competency in response to a variety of environmental perturbations. Although this method provides information regarding the impact of the vaccine formulation, it involves an empirical approach to evaluate stability. Biophysical studies on the other hand have the potential to provide insight into the mechanisms of inactivation of a viral vaccine in response to a variety of stressed conditions. Herein, we have employed a variety of spectroscopic techniques (i.e., circular dichroism, fluorescence spectroscopy, and dynamic light scattering) for a comprehensive examination of the thermal stability of three live-attenuated human-bovine reassortant rotavirus strains (G1, G3, and G4) in the 5-8 pH range. The spectroscopic methods employed are not specific and response changes reflect an average change over the entire virus structure. The present work, however, suggests the utility of these methods in early formulation of rotaviral vaccines due to their ability to identify regions of marginal stability over which high throughput excipient screening assays can be designed. We have further shown that these methods are sufficiently sensitive to differentiate the stability of the three homologous G-subtypes differing only in the composition of their surface antigenic proteins. The data from these spectroscopic methods are also compared to biological activity using a tissue culture viral infectivity assay. Partial correlation between the structural alterations and losses in activity are observed, further suggesting the utility of biophysical studies in early formulation studies of rotavirus vaccines.


Journal of Pharmaceutical Sciences | 2007

Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.

Ahmad M. Abdul‐Fattah; Vu Truong-Le; Luisa Yee; Lauren Nguyen; Devendra S. Kalonia; Marcus T. Cicerone; Michael J. Pikal


Pharmaceutical Research | 2007

Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.

Ahmad M. Abdul-Fattah; Vu Truong-Le; Luisa Yee; Emilie Pan; Yi Ao; Devendra S. Kalonia; Michael J. Pikal


Archive | 2004

Methods of producing inflenza vaccine compositions

George Robert Trager; George Kemble; Richard Schwartz; Harshvardhan Mehta; Vu Truong-Le; Zhongying Chen; Alfred A. Pan; Eric Tsao; Chiaoyin Kathy Wang; Luisa Yee; Palani Balu


Archive | 2010

Methods and Compositions for Stabilization of a Virus Vaccine

Satoshi Ohtake; Vu Truong-Le; Luisa Yee; Russell A. Martin; David Lechuga-Ballesteros


Archive | 2008

Sonic low pressure spray drying

Vu Truong-Le; Satoshi Ohtake; Russell A. Martin; Binh Pham; Luisa Yee


Archive | 2008

FORMULATIONS FOR PRESERVATION OF ROTAVIRUS

Vu Truong-Le; Luisa Yee; David Lechuga-Ballesteros; Satoshi Ohtake


Pharmaceutical Research | 2016

Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying

Phillip M. Lovalenti; Jeff Anderl; Luisa Yee; Van Nguyen; Behnaz Ghavami; Satoshi Ohtake; Atul Saxena; Thomas Voss; Vu Truong-Le

Collaboration


Dive into the Luisa Yee's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satoshi Ohtake

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge